au.\*:("VASQUEZ, E. M")
Results 1 to 17 of 17
Selection :
Sirolimus : A new agent for prevention of renal allograft rejectionVASQUEZ, E. M.American journal of health-system pharmacy. 2000, Vol 57, Num 5, pp 437-448, issn 1079-2082Article
Effect of oral pentoxyfylline on the OKT3-induced cytokine-release syndrome among renal allograft recipientsVASQUEZ, E. M; POLLAK, R.Clinical transplantation. 1996, Vol 10, Num 3, pp 294-297, issn 0902-0063Article
Effect of pretransplant erythropoitein therapy on renal allograft outcomeVASQUEZ, E. M; POLLAK, R.Transplantation. 1996, Vol 62, Num 7, pp 1026-1028, issn 0041-1337Article
Effect of calcium channel blockers on graft outcome in cyclosporine-treated renal allograft recipientsVASQUEZ, E. M; POLLAK, R.Transplantation. 1995, Vol 60, Num 8, pp 885-887, issn 0041-1337Article
OKT3 therapy increases cyclosporine blood levelsVASQUEZ, E. M; POLLAK, R.Clinical transplantation. 1997, Vol 11, Num 1, pp 38-41, issn 0902-0063Article
Transplant pharmacists' opinions on generic product selection of critical-dose drugsVASQUEZ, E. M; MIN, D. I.American journal of health-system pharmacy. 1999, Vol 56, Num 7, pp 615-621, issn 1079-2082Conference Paper
The impact of quadruple immunosuppression with OKT3 on kidney transplantation in black recipientsBENEDETTI, E; FREELS, S. A; COADY, N. T et al.The American journal of surgery. 1996, Vol 172, Num 1, pp 56-60, issn 0002-9610Article
Clinically significant drug interaction between basiliximab and tacrolimus in renal transplant recipientsSIFONTIS, N. M; BENEDETTI, E; VASQUEZ, E. M et al.Transplantation proceedings. 2002, Vol 34, Num 5, pp 1730-1732, issn 0041-1345Conference Paper
Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patientsVASQUEZ, E. M; SIFONTIS, N. M; POLLAK, R et al.Clinical transplantation. 2001, Vol 15, Num 4, pp 253-257, issn 0902-0063Article
A prospective randomized clinical trial of perioperative treatment with octreotide in pancreas transplantationBENEDETTI, E; COADY, N. T; ASOLATI, M et al.The American journal of surgery. 1998, Vol 175, Num 1, pp 14-17, issn 0002-9610Article
Antibody-mediated hemolytic anemia following ABO-mismatched organ transplantation : contributory role of HLA matching and polyclonal antilymphocyte globulinFABREGA, A. J; DECHRISTOPHER, J; SOSLER, S. D et al.Clinical transplantation. 1996, Vol 10, Num 2, pp 166-169, issn 0902-0063Article
High-dose oral acyclovir prophylaxis for primary cytomegalovirus infection in seronegative renal allograft recipientsVASQUEZ, E. M; SANCHEZ, J; POLLAK, R et al.Transplantation. 1993, Vol 55, Num 2, pp 448-450, issn 0041-1337Article
Transplant immunopharmacology : You can fool with mother nature!VASQUEZ, E. M; WESTIN, E. D.Nursing case management. 1999, Vol 4, Num 1, pp 37-48, issn 1084-3647Article
Value of perioperative treatment with sandostatin after pancreas transplantation : A prospective randomized trialBENEDETTI, E; COADY, N. T; ASOLATI, M et al.Transplantation proceedings. 1998, Vol 30, Num 2, pp 432-433, issn 0041-1345Conference Paper
Late acute rejection is more prevalent among African-American renal allograft recipients and is frequently associated with allograft lossVASQUEZ, E. M; BENEDETTI, E; POLLAK, R et al.Transplantation proceedings. 1998, Vol 30, Num 4, pp 1173-1175, issn 0041-1345Conference Paper
Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycinVASQUEZ, E. M; MADDUX, M. S; SANCHEZ, J et al.Archives of internal medicine (1960). 1993, Vol 153, Num 7, pp 879-882, issn 0003-9926Article
Clotrimazole increases tacrolimus blood levels : a drug interaction in kidney transplant patientsVASQUEZ, E. M; POLLAK, R; BENEDETTI, E et al.Clinical transplantation. 2001, Vol 15, Num 2, pp 95-99, issn 0902-0063Article